VIP and migraine disorder: A study investigating the efficiency of CGRP, PACAP, and VIP as migraine biomarkers using blood samples derived from chronic migraineurs, episodic migraineurs, and healthy controls revealed that VIP and PACAP could increase the risk of chronic migraines but not that of recurrent migraines.